Stoke Therapeutics Inc
F:0GT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Stoke Therapeutics Inc
F:0GT
|
US |
|
E
|
Emperor Entertainment Hotel Ltd
XMUN:EM7A
|
HK |
|
E
|
Eisai Co Ltd
F:EII
|
JP |
|
F
|
Founder Holdings Ltd
SWB:FOU1
|
HK |
|
M
|
Meidensha Corp
XBER:MW7
|
JP |
|
S
|
Sosei Group Corp
F:JSS
|
JP |
|
P
|
Progress Software Corp
F:PGR
|
US |
|
S
|
Seaboard Corp
F:S0V
|
US |
|
U
|
Ucb SA
XMUN:UNC
|
BE |
|
D
|
Deutsche Pfandbriefbank AG
XBER:PBB
|
DE |
|
S
|
Sensirion Holding AG
F:1Q3
|
CH |
|
N
|
Novra Technologies Inc
F:7CV
|
CA |
Wall St Price Targets
0GT Price Targets Summary
Stoke Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
0GT is 43.72 EUR with a low forecast of 33.07 EUR and a high forecast of 58.94 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0GT's stock price target?
Price Target
43.72
EUR
According to Wall Street analysts, the average 1-year price target for
0GT is 43.72 EUR with a low forecast of 33.07 EUR and a high forecast of 58.94 EUR.
What is the Revenue forecast for Stoke Therapeutics Inc?
Projected CAGR
28%
The compound annual growth rate for Revenue over the next 8 years is 28%.